OpenLegislation

Regulation 5 Fee for scientific advice: classification of a medicinal product

(1)

The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—

(a)

F1£8,758, if the advice relates to a product which, if reclassified, will be available on general sale; and

(b)

F2£8,758, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.

(2)

For the purposes of this regulation, a product is on general sale if it is a medicinal product subject to general sale within the meaning of regulation 5(1) of the Human Medicines Regulations (classification of medicinal products for general sale).

Annotations

Textual amendments

F1

Sum in reg. 5(1)(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 5(a)

F2

Sum in reg. 5(1)(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 5(b)